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This article examines the rationale and strategies for surveillance of health-care-associated infections in home-
care settings, the challenges of nonhospital-based surveillance, and the feasibility of developing a national sur-
veillance system.
ver the past 2 decades, the delivery of health care in the
United States has shifted increasingly from hospitals to
patients’ homes (1-3). Nearly eight million people in the
United States received medical care at home in 1996 (4), and
an estimated 774,113 (10%) of these patients had at least one
indwelling medical device (5). Use of a medical device is the
greatest predictor (exogenous) of health-care-associated infec-
tion.
Home care is often provided by family members who have
little or no formal health-care training, which may place
patients at increased risk of health-care-associated infections
not typically seen in hospitals. In the home-care setting,
patients with open wounds or central venous catheters may
undertake activities of daily living (e.g., bathing, exercising,
gardening, and playing with pets) that may increase the risk of
infections. 
Rationale for a National Surveillance System in 
Home-Care Settings
The epidemiology of health-care-associated infections in
home-care settings has not been defined, but infections cer-
tainly occur. Outbreaks have been documented in association
with use of central venous catheters, parenteral nutrition, bath-
ing practices, educational level of caregivers, and the introduc-
tion of new products, such as needleless devices for
intravenous infusion (6-8). 
Needleless devices are used for connecting and accessing
intravenous infusion tubing, replacing traditional needles.
These devices are used in both home and hospital settings and
are perceived to be safe for patients and effective in reducing
needlestick injuries. 
From 1993 through 1995, the Hospital Infections Program,
Centers for Disease Control and Prevention (CDC), investi-
gated three outbreaks of bloodstream infections (BSI) in
patients receiving infusion therapy in their homes. In all three
outbreaks, needleless devices were associated with BSIs. The
first outbreak occurred in Rhode Island in 1993-1994. The
endcaps on these devices were changed every 7 days. BSIs
were frequent when needleless devices were used to admini-
ster total parenteral nutrition (6). The second outbreak, in Oak-
land, California, during 1992-1994, occurred among pediatric
hematology-oncology patients. The BSI rate was higher when
needleless devices were used by Asian or Hispanic children
but not by white or black children. The racial/ethnic differ-
ences were thought to stem from socioeconomic factors or
possibly from language barriers that prevented full under-
standing of instructions on infection control (7). The third out-
break occurred in Houston, Texas, in 1994-1995. The BSI rate
was higher when the needleless device endcaps were changed
every 7 days and lower when they were changed every 2-3
days. Patients who showered may have had a higher BSI rate
than those who took tub baths (8).
These outbreak investigations were, by necessity, retro-
spective, and some data were difficult to obtain. To better
define the epidemiology of BSIs in the home-care setting, in
1995 the Hospital Infections Program conducted a prospective
multicenter study of home infusion therapy patients. The
objectives were to determine rates of BSI and to identify risk
factors, especially the use of needleless devices. The study,
which was conducted in Cleveland, Ohio, and Toronto, Can-
ada, involved 827 patients (69,532 catheter-days) (9). The
most common underlying diagnoses among this cohort were
infections caused by organisms other than HIV (67%), malig-
nancy (24%), nutritional and digestive disease (17%), heart
disease (14%), organ transplantation (11%), and HIV infection
(7%). 
Overall, 7% of these patients had one or more BSIs during
a median of 44 days of catheter use (range 1 to 395 catheter
days). A multivariate analysis showed that independent risk
factors included recent bone marrow transplant, receipt of total
parenteral nutrition, receipt of infusion therapy outside the
home (e.g., in a clinic or physician’s office), use of a multilu-
men catheter, and having had a previous BSI (9). Needleless
devices were not associated with BSI. 
Two prevalence surveys of infections among patients of
Missouri home health agencies were conducted by CDC in *Centers for Disease Control and Prevention, Atlanta, Georgia, USA
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collaboration with the Missouri Alliance for Home Care
(MAHC) and the Missouri Department of Health, the first dur-
ing summer (June 1-30, 1999) and the second during winter
(February 15-March 15, 2000). Of 5,100 home-care patients
enrolled in the summer survey, 16% (793) were reported to
have infections; 8% (63) of these infections were reported as
being acquired at home, 16% (127) as hospital acquired, 35%
(278) as unknown source, and 41% (325) as community
acquired. The infection sites reported were urinary tract (214
[27%]), respiratory tract (190 [24%]), skin or soft tissue (190
[24%]), surgical site (95 [12%]), or bloodstream (17 [2%]);
18% (143/793) of infections occurred at other body sites (e.g.,
gastrointestinal, bone) (10). Of 2,890 patients enrolled in the
winter survey, 16% (466) had infections. The prevalence of
respiratory tract infections was higher during the winter survey
than during the summer survey. These results suggest that an
estimated 1.2 million patients receiving home care in the
United States have infections annually, supporting a need for
surveillance of infections among home-care patients (11). 
A nationwide hospital-acquired infection surveillance sys-
tem and standardized infection definitions have been in exist-
ence since the 1970s (12-14). However, no national
surveillance or standardized definitions exist for monitoring
infections in the home-care setting. Recently, the Association
for Professionals in Infection Control and Epidemiology, Inc.
(APIC) published draft definitions for surveillance of infec-
tions in home-care patients (15). However, these definitions
have not yet been validated.
National surveillance of health-care-associated infections
in home care may potentially decrease infection rates, as has
been documented in hospitals by the National Nosocomial
Infections Surveillance system (NNIS). This voluntary, hospi-
tal-based reporting system was established to monitor hospi-
tal-acquired infections and to guide the prevention efforts of
infection control practitioners. During 1990-1999, risk-adjusted
infection rates in intensive-care units decreased by approxi-
mately 40% among hospitals participating in NNIS (16).
A national system for surveillance of health-care-associ-
ated infections in home care would not only provide useful
data on incidence and types of infections but also simplify
identification of risk factors for infection and development of
national benchmarks for comparing infection rates. Risk-
adjusted rates may assist individual home-care agencies to
identify areas for performance and quality improvement and to
evaluate the impact of prevention interventions on infection
rates.
Challenges to Developing a
National Surveillance System 
Home-care surveillance poses several unique challenges,
including lack of nationally accepted standard definitions and
surveillance methods, loss of patient follow-up, lack of trained
infection control personnel in home-care settings, difficulty in
capturing clinical and laboratory data, and difficulty in obtain-
ing numerator and denominator data.
Lack of Nationally Accepted Definitions and Methods
A cornerstone of surveillance in any setting is develop-
ment of standardized definitions and methods. Individual
home-care agencies have developed surveillance definitions
for their own use (17-20), but national definitions of infections
in home care do not exist. The draft APIC definitions of home
health-care-associated infections have yet to be accepted and
implemented nationally. These definitions should be tested to
determine their practicality or applicability, given the limited
use of laboratory diagnostics in home care. In addition, stan-
dard methods of case finding, recording, and calculating rates
are also essential. If national benchmark rates are to be estab-
lished to permit inter- and intra-agency comparisons, consen-
sus definitions of home health-care-associated infections, such
as those published by APIC, will have to be implemented.
Patient Follow-up
Home-care patients often are served by several agencies or
are readmitted to the hospital during their illness. Lack of con-
tinuity of care hampers detection and reporting of health-care-
associated infections. For example, if a home-care patient
receiving intravenous therapy has a fever, is admitted to an
acute-care facility, and is confirmed to have a BSI, this infor-
mation may not be communicated to the home-care agency
(the same or a different one) when the patient is discharged to
continue infusion therapy at home.
Lack of Trained Personnel
Surveillance requires adequately trained infection control
personnel, but few homehealth companies have such employ-
ees who are designated to conduct infection control activities,
including education, surveillance, and prevention. In a recent
survey of home-care agencies in Missouri, only 51 (54%) of
95 had a designated infection control practitioner, and only 27
(53%) of 51 provided ongoing training (21). In most home-
care agencies, infection control activities are performed on a
volunteer basis with no additional compensation. Successful
implementation of surveillance programs and other infection
control activities in the home health-care setting will require
designated and appropriately trained personnel. Training
should include calculation of infection rates, recognition of
outbreaks and clusters, providing feedback data to essential
personnel, and monitoring compliance of prevention efforts.
Educational activities targeted at patients, health-care workers,
and other caregivers will also be a necessary part of the infec-
tion control program.
Difficulty in Capturing Clinical and Laboratory Data
Many home-care agencies are privately owned and have
no hospital or laboratory affiliation; therefore, access to diag-
nostic services may be limited, and home-care personnel may
have difficulties in tracking laboratory results (e.g., contacting
out-of-state physician offices or laboratories). Limited access
to test results may also encourage home-care personnel to use
empiric therapy without documentation of infection orEmerging Infectious Diseases  •  Vol. 8, No. 3, March 2002 235
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identification of a causative pathogen. Linkages for sharing
clinical and laboratory data among physicians, hospitals, and
home-care agencies are essential to optimize patient care in the
home.
Difficulty in Obtaining Numerator and Denominator Data
Surveillance for infections in home care will require meth-
ods to identify appropriate numerator and denominator data
for calculating infection rates for inter- and intra-agency com-
parison and benchmarks. Collection of numerator data (e.g.,
BSI or other infectious complications) will require systems
that permit data sharing by hospitals and laboratories with
home-health agencies.
Capturing appropriate denominator data may even be more
difficult (22). For example, to determine device-associated
infection rates, device utilization must be measured by moni-
toring days of use. However, if insertion, care, and removal of
the device (e.g., central venous catheter, urinary catheter, tra-
cheostomy tube) are done in different health-care settings, it
will be difficult to monitor how many days a device is used.
Although infection rates based on device utilization have been
shown to be necessary in the acute-care setting, it is not certain
that they are necessary in home care. 
Another option for denominator is the number of days a
patient uses a device during home care only, rather than the
total number of days (i.e., from insertion to removal) the
device is used. Because all home infusion therapy patients
have intravenous catheters, patient days may be substituted for
device days as long as they equal one another.
In addition to these challenges, the home-care industry will
have to deal with the financial implications of implementing
and maintaining a national surveillance system. Data on the
cost of a surveillance system and on methods of calculating
that cost into the reimbursement systems of health-care payors
are very much needed. 
Despite cost concerns, patient safety and outcomes are
becoming increasingly important in the current health-care
environment. Purchasers should base their selection of a
home-care agency on patient outcomes and satisfaction rather
than cost. Thus, home care agencies must conduct surveillance
for adverse events. Without such surveillance systems, it
would be very difficult for agencies to know if problems are
occurring and whether quality care is being provided. 
Progress Toward a National Surveillance System
for Health-Care-Associated Infections
Several groups are collecting data on health-care-associ-
ated infections in home care and other outpatient areas. These
data may prove useful in developing a national home health-
care surveillance system.
MAHC is a nonprofit association that provides home care
education, advocacy, and information for its 250-member
agencies, most of which are located in Missouri. In the early
1990s, MAHC established an infection control committee
composed of nurses who provided infection control activities
for their agencies. In 1993, the committee implemented the
MAHC Infection Surveillance Project (ISP) to monitor infec-
tions associated with central venous and urinary catheters. ISP
is an active surveillance system that uses standardized criteria
and definitions for tracking, aggregating, and reporting urinary
infections and BSIs among home-care patients. Currently, 88
home-care agencies from 23 states participate in ISP. Although
MAHC has contracted with the Hospital Industry Data Insti-
tute, Missouri Hospital Association, to organize and present
the ISP data, the results have not yet been published. Although
the ISP definitions have not been validated to determine sensi-
tivity and specificity, the data allow participating agencies to
compare their infection rates with those of other agencies. 
On a broader scale, the Health Care Financing Administra-
tion (HCFA), in collaboration with the Center for Health Sci-
ences and Policy Research, has developed the Outcome and
Assessment Information Set (OASIS) to measure patient out-
comes and improve quality in home care. HCFA requires all
Medicare-certified home-care agencies to electronically sub-
mit data for their Medicare patients to a central OASIS data-
base in Baltimore, Maryland. The outcomes monitored in
OASIS are changes in patient health status, as indicated by
need for emergency care or hospitalization, for example. Data
collected include patient demographics and medical history,
living arrangements, type of wound, urinary tract infection,
respiratory devices, medications, emergency care received,
transfer to an inpatient facility, and death. Most data items are
obtained at start of care, every two calendar months, and at
discharge. Since August 1999, eight million records have been
entered into the OASIS database, and release of an initial
report is anticipated in 2001 after the data are tested for accu-
racy (HCFA, pers. comm.)
Another national and international data source is the Out-
patient Parenteral Antimicrobial Therapy (OPAT) registry,
which aims to improve delivery of care and outcomes for out-
patients receiving parenteral antimicrobial therapy. OPAT pro-
vides a broad database for assessing antimicrobial drug-
prescribing practices and outcomes among patients with infec-
tions treated in outpatient settings. Data collected include
patient demographics, diagnosis, pathogen, venous access
device, infusion system, adverse events, clinical outcome, and
patient satisfaction. Currently, 23 OPAT provider sites from 19
states are participating in the U.S. registry, and 26 provider
sites from 6 countries are in the international registry. OPAT
data have been presented at scientific conferences (23).
Surveillance methods that are commonly used in hospital
programs may not be feasible for home care. Different strate-
gies are needed to make surveillance in the home easier to
implement, particularly if adequately trained staff and diag-
nostic services are limited. For example, the Dialysis Surveil-
lance Network provides a novel way of tracking
hospitalization, antimicrobial use, and selected infections in
hemodialysis outpatients (24). Episodes of potential infection
are identified by a clearly defined sequence of steps that
involves completing an “incident form” for all patientsPERSPECTIVES
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admitted to a hospital or started on intravenous antimicrobial
therapy. The presence (or absence) of symptoms indicating
infection is recorded rather than the infections themselves, and
a computer algorithm determines whether the infection case
definitions are met; the data collector is not required to memo-
rize case definitions. The lessons from this surveillance sys-
tem, in addition to other traditional outpatient systems, may be
useful in establishing national surveillance for home health-
care-associated infections.
Nearly as many patients receive home care annually as
hospital care. With the continued expansion of home health-
care delivery and documented infection risk in this setting, a
national system for surveillance of health-care-associated
infections in the home-care setting is needed. Collaboration
between home health-care agencies, state and federal health
agencies, private industry, and national or managed-care orga-
nizations is essential to make this system feasible and func-
tional. Development and implementation of such a system
would foster better understanding of the epidemiology of
health-care-associated infections in the home-care setting. Fur-
thermore, this system would provide a means for monitoring
the impact of interventions aimed at preventing the emergence
of these infections in the home. 
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